Skip to main content

Apple Watch Series 7 has resolved production issues and will launch this month

MacRumors is reporting Apple has resolved its Apple Watch Series 7 production issues and will begin producing and launching the new model this month, according to Apple Insider analyst Ming-Chi Kuo. Nikkei Asia and Bloomberg reported there could have been delays because of these production issues. Bloomberg journalist Mark Gurman recently tweeted the device will be available in limited quantities at launch.

The watch has a new, more durable display panel and a contact design instead of the older cable design. It has a flat-edged look modeled after the designs of the iPhone 12 and iPad Pro. This created a more complicated production process.

Recommended Videos

The production issue was related to the complex new panel modules having reliability issues. These issues included a blinking panel and touch insensitivity. The problem was solved by going experimenting with different designs to determine the best production configuration. Qualification standards for the panel and assembly sides also had to be adjusted.

For the first time, a low-injection pressure overmolding was used to protect the inner components. A new OLED production line was used to reduce costs and improve efficiency. A longer supply chain may have contributed to the delays because of the addition of new suppliers like LG Display, Young Poong, and Jabil.

“We expect Jabil to start mass production of Apple Watch 7 panel modules in mid-September,” said Kuo.

Kuo’s note is optimistic about the future of Apple Watch shipments and mentioned “new health-management features” for the Series 8. This is encouraging news for Apple users as Gurman said there would be “no chance” of any additional health features for the Series 7.

The Apple Watch Series 7 displays will be larger than previous models. Currently, they come in 40mm and 44mm sizes. The new series should be 41mm and 45mm. Apple will release its new product lineup at 10 a.m. PT on Tuesday, September 14 and you can watch it live.

Williesha Morris
Former Digital Trends Contributor
Williesha Morris is an Alabama-based freelance journalist and copywriter currently focusing on accessibility, mental health…
The Apple Watch Series 10 has ruined smartwatches for me
A person wearing the aluminum Apple Watch Series 10.

That’s it, the Apple Watch Series 10 has ruined other smartwatches for me. This week I will swap to another smartwatch I have to review, but I don’t want to take the Apple Watch off. It's wonderful.

I don’t want to use the word perfect because, of course, it’s not, but it’s very, very close to it. Prepare for some gushing over the next few hundred words, as I’m going to explain why if you’re looking for a smartwatch, the search can stop with the Apple Watch Series 10.
Why don’t I want to take it off?

Read more
I already damaged my Apple Watch Series 10
i already damaged my apple watch series 10 dt 1

I don’t think I’m clumsy, but I swing my arms a lot and still grimace every time a smartwatch on my wrist hits an immovable object. Yet, for all this movement, I’ve never managed to deeply scratch or lightly crack an Apple Watch display … until now.

The Apple Watch Series 10 doesn’t have many compromises over the Apple Watch Ultra 2, and I even made the switch permanently before this happened. It’s big, thin, and beautiful, but the Apple Watch Series 10 also uses a less durable protective shield for its display.

Read more
Blood oxygen tracking isn’t coming back to the Apple Watch anytime soon
Apple Watch Ultra taking a measurement for blood oxygen levels.

One of the major selling points of Apple Watches in recent years has been the ability to test users’ blood oxygen levels. Unfortunately, ongoing litigation has prevented this feature from being included in Apple Watches sold in the U.S. since January. Now, it seems unlikely that this situation will change soon.

On Friday, a Delaware jury found that health-monitoring technology company Masimo infringed on some of Apple’s earlier smartwatch patents. As a result, Apple received an award of only $250. However, the same jury ruled that Masimo's current watches did not infringe on the patents that Apple accused it of copying. Consequently, an injunction remains in effect in the U.S. that prevents the company from offering blood oxygen tracking on new watches sold in the country.

Read more